UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000037006
Receipt number R000042161
Scientific Title Comparison of Polaris Ultra Ureteral Stent and Tria Firm Ureteral Stent on Deposition of Encrustation Following Short-Term Placement: A Prospective, Single-blind, Randomized Controlled Trial.
Date of disclosure of the study information 2019/06/20
Last modified on 2020/12/09 13:54:47

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Comparison of Polaris Ultra Ureteral Stent and Tria Firm Ureteral Stent on Deposition of Encrustation Following Short-Term Placement: A Prospective, Single-blind, Randomized Controlled Trial.

Acronym

Comparison of Polaris Ultra Ureteral Stent and Tria Firm Ureteral Stent on Deposition of Encrustation Following Short-Term Placement

Scientific Title

Comparison of Polaris Ultra Ureteral Stent and Tria Firm Ureteral Stent on Deposition of Encrustation Following Short-Term Placement: A Prospective, Single-blind, Randomized Controlled Trial.

Scientific Title:Acronym

Comparison of Polaris Ultra Ureteral Stent and Tria Firm Ureteral Stent on Deposition of Encrustation Following Short-Term Placement

Region

Japan


Condition

Condition

Patients with urolithiasis

Classification by specialty

Urology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate whether Tria Firm Ureteral Stent prevents the deposition of encrustation compared to Polaris Ultra Ureteral Stent after short-term placement

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase

Phase IV


Assessment

Primary outcomes

Encrustation volume in inner wall of the ureteral stent (mm3)

Key secondary outcomes

1. Intraluminal obstruction rate (%) (at the narrowest point of the stent)
2. Outerwall stent encrustation volume (mm3)
3. Outerwall stent encrustation-sectional volume: proximal/body/distal (mm3)
4. Hydronephrosis grade before removal of stents
5. Stent-related complications (Dislodgment, migration, UTI, readmission etc.)
6. Stone composition (stone fragments, encrustation stone)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Active

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Placement of Tria Firm Ureteral Stent during 14 days postoperatively

Interventions/Control_2

Placement of Polaris Ultra Ureteral Stent during 14 days postoperatively

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.>20 year-old adults
2.Patients undergoing ureteroscopy (URS) for renal and/or ureteral stones
3.Patients with informed consent

Key exclusion criteria

1. Patients potentially requiring ureteric stent placement for >14 days postoperatively
2. Patients requiring antibiotics use prior to URS due to the presence of urinary tract infection
3. Pregnant
4. Patients with difficulty of communication
5. patients who have been determined to be unsuitable as a subject by a physician

Target sample size

80


Research contact person

Name of lead principal investigator

1st name Takashi
Middle name
Last name Yoshida

Organization

Kansai medical university hospita

Division name

Department of Urology and Andrology

Zip code

573-1010

Address

2-3-1 Shin-Machi, Hirakata, 573-1010, Osaka, Japan

TEL

072-804-0101

Email

yoshidtk@takii.kmu.ac.jp


Public contact

Name of contact person

1st name Takashi
Middle name
Last name Yoshida

Organization

Kansai medical university hospital

Division name

Department of Urology and Andrology

Zip code

573-1010

Address

2-3-1 Shin-Machi, Hirakata, 573-1010, Osaka, Japan

TEL

072-804-0101

Homepage URL


Email

yoshidtk@takii.kmu.ac.jp


Sponsor or person

Institute

Department of Urology and Andrology, Kansai medical university

Institute

Department

Personal name



Funding Source

Organization

Self-funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

Kansai medical university, Department of phisic
Kansai medical university, kori hospital
Wakayama prefectureal medical univeresity hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethic Committee of Kansai medical university

Address

2-3-1 Shin-Machi, Hirakata, 573-1191, Osaka, Japan

Tel

(072)-804-2083

Email

kenkyu@hirakata.kmu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 06 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2019 Year 06 Month 01 Day

Date of IRB

2019 Year 06 Month 17 Day

Anticipated trial start date

2019 Year 07 Month 01 Day

Last follow-up date

2019 Year 10 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 06 Month 09 Day

Last modified on

2020 Year 12 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042161


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name